Prevenar Multidose
Active ingredient not listed in the SAHPRA register
Pfizer Laboratories (Pty) Ltd
Registration
- Applicant
- Pfizer Laboratories (Pty) Ltd
- Certificate holder
- Pfizer Laboratories (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Prevenar 13 multidose vial EACH 0,5 ml DOSE CONTAINS: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 31 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 41 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 51 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A1 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B1 4,4 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F1 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V1 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 141 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C1 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A1 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F1 2,2 μg PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F1 2,2 μg | 13Suspension for injection in multidose container | 61099961/30.2/0999Approved 9 June 2026 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
The SAHPRA register lists no active ingredient for this product, so there is no compound to show.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.